UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010095 |
|---|---|
| Receipt number | R000011780 |
| Scientific Title | A Phase II, Open-label Single-Arm Study to Evaluate the efficacy and Safety of Vandetanib in Patients with RET Fusion-positive Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer |
| Date of disclosure of the study information | 2013/02/22 |
| Last modified on | 2016/12/14 09:53:13 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/02/22 17:08:57 | ||
| 2 | Update | 2013/03/01 16:53:16 | Co-sponsor Co-sponsor |
|
| 3 | Update | 2016/12/13 17:30:34 | UMIN ID1 |
|
| 4 | Update | 2016/12/14 09:42:55 | Recruitment status Publication of results URL related to results and publications |
|
| 5 | Update | 2016/12/14 09:53:13 | Email TEL Name of primary person or sponsor Organization Organization Organization Category of Funding Organization Co-sponsor Co-sponsor Organization1 |
